Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancerBonnita Werner, Caroline E. Ford, Nicole Laurencia Yuwono et al.|Gynecologic Oncology|2021Cited by 42
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancerPaul A. Cohen, Michael Friedländer, Val Gebski et al.|International Journal of Gynecological Cancer|2021Cited by 12